Abstract

ObjectivesTo develop prognostic models for time to 12-month remission and time to treatment failure after initiating antiepileptic drug monotherapy for generalised and unclassified epilepsy.MethodsWe analysed data from the Standard and...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Treatment outcome after failure of a first antiepileptic drug.
Laura J Bonnett ... Anthony G Marson
Neurology | VOL. 83
Laura J Bonnett, et. al.Laura J Bonnett ... Anthony G Marson
03 Jul 2014
Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Sarah J Nevitt ... Catrin Tudur Smith
The Cochrane database of systematic reviews | VOL. 6
Sarah J Nevitt, et. al.Sarah J Nevitt ... Catrin Tudur Smith
24 Jun 2019
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Sofia Cividini ... Sarah J Nevitt
The Cochrane database of systematic reviews | VOL. 4
Sofia Cividini, et. al.Sofia Cividini ... Sarah J Nevitt
01 Apr 2022
Breakthrough seizures-Further analysis of the Standard versus New Antiepileptic Drugs (SANAD) study.
Laura J Bonnett ... Hyunmi Choi
PloS one | VOL. 12
Laura J Bonnett, et. al.Laura J Bonnett ... Hyunmi Choi
21 Dec 2017
View more papers

More From: Journal of Neurology, Neurosurgery & Psychiatry

Paper Title
Journal
Date
Author
Linking LRP12 CGG repeat expansion to inherited peripheral neuropathy.
Takahiro Hobara ... Hiroshi Takashima
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Takahiro Hobara, et. al.Takahiro Hobara ... Hiroshi Takashima
16 Jul 2024
Vitamin D affects the risk of disease activity in multiple sclerosis
Antonino Giordano ... Federica Esposito
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Antonino Giordano, et. al.Antonino Giordano ... Federica Esposito
13 Jul 2024
Induction cyclophosphamide with maintenance immunosuppression in high-risk myasthenia gravis: long-term follow-up and safety profile
Fiona Chan ... Stephen W Reddel
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Fiona Chan, et. al.Fiona Chan ... Stephen W Reddel
04 Jul 2024
Cyclophosphamide for myasthenia gravis: a comeback?
Carolina Barnett-Tapia ... Hans D Katzberg
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Carolina Barnett-Tapia, et. al.Carolina Barnett-Tapia ... Hans D Katzberg
04 Jul 2024
View more papers